Showing results (171-180 of 368) with videos related to

Sort By:
Pageof 37
Journal of Health Economics and Outcomes Research|May 8, 2025
Impact of Digital Navigation on Screening Adherence With the Multi-Target Stool DNA TestMallik Greene, Timo Pew, A Burak Ozbay, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 16, 2003
Use of pharmacoeconomics information--report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision makingMichael Drummond, Ruth Brown, A Mark Fendrick, et al.
Population Health Management|December 15, 2023
Expanding the Catalog of Patient and Caregiver Out-of-Pocket Costs: A Systematic Literature ReviewTheresa Schmidt, Christine Juday, Palak Patel, et al.
BMC Health Services Research|July 3, 2023
Evaluating the accessibility and value of U.S. ambulatory care among Medicaid expansion states and non-expansion states, 2012-2015Aaron Parzuchowski, Carlos Oronce, Rong Guo, et al.
BMC Health Services Research|March 26, 2011
Emergency department documentation templates: variability in template selection and association with physical examination and test ordering in dizziness presentationsKevin A Kerber, Timothy P Hofer, William J Meurer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Self-selection and use patterns of over-the-counter omeprazole for frequent heartburnA Mark Fendrick, Michael Shaw, Bernard Schachtel, et al.
Health Affairs (Project Hope)|November 13, 2004
Barriers to constraining health care cost growthMichael E Chernew, Peter D Jacobson, Timothy P Hofer, et al.
Medical Care|September 17, 2013
The impact of out-of-pocket costs on the use of intrauterine contraception among women with employer-sponsored insuranceLydia E Pace, Stacie B Dusetzina, A Mark Fendrick, et al.
Gastro Hep Advances|July 21, 2025
Adherence to Follow-Up Colonoscopy After a Positive Stool-Based Test in Patients Aged 45-49 Years: Real-World Differences Between Multitarget Stool DNA Testing and Fecal Immunochemical or Fecal Occult Blood TestingMallik Greene, Brad Stieber, A Burak Ozbay, et al.
The American Journal of Gastroenterology|June 20, 2020
Clinical and Economic Outcomes of Patients Undergoing Guideline-Directed Management of Pancreatic CystsJennifer M Lobo, James M Scheiman, Victor M Zaydfudim, et al.
Pageof 37